Eoflow Co Investor Relations Material

Eoflow Co., Ltd. is a South Korean medical device company specializing in the development and production of wearable drug delivery systems, with a focus on insulin delivery for diabetes management. The company’s primary product is a compact, wearable insulin pump designed to provide continuous and precise insulin administration, supporting the needs of individuals with diabetes. Eoflow leverages advanced microfluidic and electrochemical technology to enhance device functionality and user convenience. The company is headquartered in Seongnam, South Korea, and its shares are listed on the KOSDAQ.